Enzo, ABI Lose New Trial Bids After $49M DNA Patent Verdict

Law360, Los Angeles (August 2, 2013, 10:38 PM EDT) -- A Connecticut federal judge Thursday denied plaintiffs' and defendants' requests for a new trial in a patent infringement dispute over whether Applied Biosystems Inc. infringed Enzo Biochem Inc.’s DNA sequencing systems, a fight that ended in a $48.6 million verdict for Enzo.

U.S. District Judge Janet Bond Arderton ruled against both parties’ posttrial motions for a new trial, ruling that Enzo deserved no more damages than it was awarded at trial for ABI’s alleged infringements. Further, the new evidence introduced by the defendants wasn’t sufficient to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.